Search Instructions:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Browse Items (107 total)
-
Creator: Wright, David J. M.
Subject: Laboratory
Item Type: Publication
Date Last Updated: 2020-05-07
Description: The Comment by Marc Feldman and colleagues,1 published recently in The Lancet, discussed the potential of anti-tumor necrosis factor (TNF) therapy to inhibit development of a cytokine storm in patients with coronavirus disease 2019 (COVID-19).… -
Creator: the ACTT-1 Study Group Members
Subject: Treatment & Care
Item Type: Publication
Date Last Updated: 2020-05-22
Description: Discussing "a double-blind, randomized, placebo-controlled trial of intravenous remdesivir in adults hospitalized with Covid-19 with evidence of lower respiratory tract involvement." -
Creator: National Institute of Allergy and Infectious Diseases (NIAID)
Subject: Research
Item Type: Hyperlink
Date Last Updated: 2020-05-07
Description: This study is an adaptive, randomized, double-blind, placebo-controlled trial to evaluate the safety and efficacy of novel therapeutic agents in hospitalized adults diagnosed with COVID-19. The study is a multicenter trial that will be conducted in… -
Creator: Meng, Xianmin, Yun Ling, Li Zhang, Qian Zhang, Ping Dong, Tongyu Zhu, and Hongzhou Lu.
Subject: Treatment & Care
Item Type: Publication
Date Last Updated: 2020-06-11
Description: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has become a serious public health threat to the whole world, and the number of infected is still rising dramatically at this moment. Several studies have confirmed that cytokine…Example only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.
-
Creator: Tedder, Richard S., and Malcolm G. Semple.
Subject: Laboratory
Item Type: Publication
Date Last Updated: 2020-06-15
Description: We read with considerable interest the Comment from Long Chen and colleagues about the potential use of convalescent plasma for the treatment of COVID-19. -
Creator: Iversen, Patrick L., Christopher D. Kane, Xiankun Zeng, Rekha G. Panchal, Travis K. Warren, Sheli R. Radoshitzky, Jens H. Kuhn, Rajini R. Mudhasani, Christopher L. Cooper, Amy C. Shurtleff, Farooq Nasar, Melek M. E. Sunay, Allen J. Duplantier, Brett…
Subject: Research
Item Type: Publication
Date Last Updated: 2020-06-18
Description: The PALM trial in the Democratic Republic of the Congo identified a statistically significant survival benefit for two monoclonal antibody-based therapeutics in the treatment of acute Ebola virus disease; however, substantial gaps remain in improving… -
Creator: Geleris, Joshua, Yifei Sun, Jonathan Platt, Jason Zucker, Matthew Baldwin, George Hripcsak, Angelena Labella, Daniel K. Manson, Christine Kubin, R. Graham Barr, Magdalena E. Sobieszczyk, and Neil W. Schluger.
Subject: Research
Item Type: Publication
Date Last Updated: 2020-06-18
Description: Hydroxychloroquine has been widely administered to patients with Covid-19 without robust evidence supporting its use. -
Creator: CDC
Subject: Training and Exercises
Item Type: Exercise
Date Last Updated: 2020-06-26
Description: Training materials on: Clinical Care & Infection Control, Personal Protective Equipment (PPE), Nonpharmaceutical Interventions (NPIs), Emergency Preparedness and Response, and Additional Topics. -
Creator: The RECOVERY Collaborative Group.
Subject: Research
Item Type: Publication
Date Last Updated: 2020-07-17
Description: Coronavirus disease 2019 (Covid-19) is associated with diffuse lung damage. Glucocorticoids may modulate inflammation-mediated lung injury and thereby reduce progression to respiratory failure and death. -
Creator: Normand, Sharon-Lise T.
Subject: Treatment & Care
Item Type: Publication
Date Last Updated: 2020-07-21
Description: In a platform trial, patients with a single disease are randomly assigned to a group of different therapies on the basis of a decision algorithm to determine whether any therapy has benefit.